People · Operator
Named in public records as an officer, director or promoter · active 2018–2025 · Biotechnology, Healthtech, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Neuros Medical, Inc. | — | Biotechnology | Series C | $160.0M | $338.1M | 2025 |
| ShockWave Medical, Inc. | — | Healthtech | Series C | $144.8M | $255.8M | 2018 |
| Miach Orthopaedics Inc. | — | Other Health Care | Series C | $67.8M | $44.0M | 2024 |
| Iantrek, Inc. | — | Biotechnology | Series B | $58.2M | $152.2M | 2025 |
| CurvaFix, Inc. | — | Other Health Care | Series C | $50.7M | $477.8M | 2020 |
| Cagent Vascular, Inc. | — | Other Health Care | Series B | $48.5M | $213.4M | 2021 |
Marc-Andre Marcotte at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Marc-Andre Marcotte on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Joyce Erony | 2 | 8 |
| Stephen Bloch | 1 | 15 |
| Casey Tansey | 1 | 14 |
| Frederic Moll | 1 | 10 |
| Frederic H. Moll | 1 | 8 |
| Peter Schneider | 1 | 8 |
| Fouad Azzam | 1 | 8 |
| Brian Walsh | 1 | 7 |
| Eric Bell | 1 | 7 |
| Mark Foster | 1 | 6 |
| ANTOINE PAPIERNIK | 1 | 6 |
| Jay Watkins | 1 | 6 |
| Trevor Moody | 1 | 5 |
| Anthony J. Natale | 1 | 5 |
| Tsontcho Ianchulev | 1 | 5 |
| Kurt Jacobus | 1 | 5 |
| Douglas Godshall | 1 | 4 |
| Daniel Hawkins | 1 | 4 |
| Dennis McGrath | 1 | 4 |
| James Mazzo | 1 | 4 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.